# CVRx (CVRX.US)

Canonical: https://gigainvestors.com/s/CVRX

Analysis as of: 2026-10-16T07:27:51.120Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $1.39 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

## Price story

Down 96% since Dec 2023

Story as of 2026-10-16T10:01:29.732Z; price observation 2026-10-15.

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in medical devices; annual sales are USD 56.7 million.

- Source: https://www.sec.gov/Archives/edgar/data/1235912/000110465926014708/cvrx-20251231x10k.htm (filed 2026-02-13); FY2025: revenue 56651000; grossProfit 48340000; margin = grossProfit / revenue.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-04); CVRX.US: CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

### Why customers stay

Margins ranged from 83.8% to 85.3% during 2023–25.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); FY2023: grossProfit / revenue = 84.1%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); FY2024: grossProfit / revenue = 83.8%.

- Source: https://www.sec.gov/Archives/edgar/data/1235912/000110465926014708/cvrx-20251231x10k.htm (filed 2026-02-13); FY2025: grossProfit / revenue = 85.3%.

### Where the cash goes

Paid no dividends in 5 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); Dividend observations: [[2021,0],[2022,0],[2023,0],[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

### What the price says

The price is 0.6 times annual sales; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-02-13); Closing price 1.39 USD; reporting-to-trading FX 1; FY2025 annual sales per share 2.1718087788520086; price multiple 0.6400195143951563. FY2025 cash earnings/share -2.036825482699462. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2021-06: $28.00 per share

- 2021-07: $19.74 per share

- 2021-08: $19.06 per share

- 2021-09: $16.54 per share

- 2021-10: $16.91 per share

- 2021-11: $11.58 per share

- 2021-12: $12.23 per share

- 2022-01: $8.30 per share

- 2022-02: $8.78 per share

- 2022-03: $5.99 per share

- 2022-04: $6.23 per share

- 2022-05: $6.21 per share

- 2022-06: $6.01 per share

- 2022-07: $8.83 per share

- 2022-08: $7.25 per share

- 2022-09: $9.33 per share

- 2022-10: $10.08 per share

- 2022-11: $13.38 per share

- 2022-12: $18.35 per share

- 2023-01: $15.20 per share

- 2023-02: $11.12 per share

- 2023-03: $9.32 per share

- 2023-04: $11.64 per share

- 2023-05: $12.52 per share

- 2023-06: $15.44 per share

- 2023-07: $17.93 per share

- 2023-08: $17.35 per share

- 2023-09: $15.17 per share

- 2023-10: $13.38 per share

- 2023-11: $20.47 per share

- 2023-12: $31.44 per share

- 2024-01: $25.12 per share

- 2024-02: $19.63 per share

- 2024-03: $18.21 per share

- 2024-04: $15.51 per share

- 2024-05: $6.95 per share

- 2024-06: $11.99 per share

- 2024-07: $8.55 per share

- 2024-08: $9.86 per share

- 2024-09: $8.81 per share

- 2024-10: $13.12 per share

- 2024-11: $15.32 per share

- 2024-12: $12.67 per share

- 2025-01: $15.98 per share

- 2025-02: $12.96 per share

- 2025-03: $12.23 per share

- 2025-04: $7.32 per share

- 2025-05: $6.64 per share

- 2025-06: $5.88 per share

- 2025-07: $7.96 per share

- 2025-08: $7.85 per share

- 2025-09: $8.07 per share

- 2025-10: $10.19 per share

- 2025-11: $9.81 per share

- 2025-12: $7.10 per share

- 2026-01: $6.85 per share

- 2026-02: $8.16 per share

- 2026-03: $9.46 per share

- 2026-04: $7.51 per share

- 2026-05: $5.58 per share

- 2026-06: $5.14 per share

- 2026-07: $5.18 per share

- 2026-08: $2.96 per share

- 2026-09: $1.75 per share

- 2026-10: $1.39 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1235912/000110465926014708/cvrx-20251231x10k.htm); period 2025-12-31, filed 2026-02-13.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.